New shot could tame peanut allergies in one dose
NCT ID NCT06331728
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested a single injection of a new drug called IGNX001 in 32 adults and teens with peanut allergies. The main goal was to check safety and how the body processes the drug. Participants received either the drug or a placebo, and researchers monitored for side effects and allergic reactions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IGNX001
What this could lead to
If successful, this could lead to a single-dose treatment that reduces peanut allergy reactions, offering a new option for managing this condition.
What could go wrong
This is an early Phase 1 trial with only 32 participants, focused on safety. It may not show effectiveness, and side effects or lack of benefit are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEANUT ALLERGY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fiona Stanley Hospital
Murdoch, Western Australia, 6150, Australia
-
Monash Health, Sleep, Allergy, and Immunology
Clayton, Victoria, 3168, Australia
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
-
St Vincent's Sydney
Darlinghurst, New South Wales, 2010, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a shot tame peanut allergies? small study tests xolair
- Can allergy drugs help kids tolerate peanut and more?
- Peanut allergy patch enters human safety trials
- Could supermarket peanuts and milk cure food allergies? new study investigates.
- New daily oral treatment aims to tame peanut allergy
- Poop pills could help peanut allergy sufferers